Tilray Brands (TLRY) Cash from Investing Activities (2017 - 2026)

Tilray Brands (TLRY) reported Cash from Investing Activities of $28.9 million for Q1 2026, up 24400.0% on a YoY basis from N/an in Q1 2025, and up 149.85% quarter-over-quarter from -$58.0 million in Q4 2025.

Tilray Brands (TLRY) Cash from Investing Activities (2017 - 2026) Analysis & Trends

Tilray Brands has reported Cash from Investing Activities for 10 years, with the latest figure at $28.9 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash from Investing Activities rose 24400.0% year-over-year to $28.9 million; the trailing twelve-month figure through Feb 2026 stood at $8.9 million (up 158.62% YoY), and the FY2025 full-year result was -$46.7 million, down 136.4% from the prior year.
  • Cash from Investing Activities for Q1 2026 stood at $28.9 million, up from -$58.0 million in the prior quarter.
  • The five-year high for Cash from Investing Activities was $81.5 million in Q4 2023, with the low at -$271.4 million in Q4 2022.
  • Historically, Cash from Investing Activities has averaged -$12.6 million across 5 years, with a median of -$1.5 million in 2022.
  • Annual changes were most pronounced in 2022 — Cash from Investing Activities tumbled 3792.69% — and 2026, when it soared 24400.0%.
  • Tilray Brands' Cash from Investing Activities stood at -$271.4 million in 2022, then surged by 130.03% to $81.5 million in 2023, then tumbled by 113.16% to -$10.7 million in 2024, then tumbled by 440.84% to -$58.0 million in 2025, then jumped by 149.85% to $28.9 million in 2026.
  • The last three Cash from Investing Activities figures came in at $28.9 million (Q1 2026), -$58.0 million (Q4 2025), and $24.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 229.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -87.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 743.70 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -506.20 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -60.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -2.08 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -15.45 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 25.99 Mn
10 Tilray Brands - - 54.95 Mn 28.92 Mn

Historic Data

Download Data
DateValue
Feb 28, 2026 28.92 Mn
Feb 28, 2026 28.92 Mn
Nov 30, 2025 -58.01 Mn
Nov 30, 2025 -58.01 Mn
Aug 31, 2025 24.47 Mn
Aug 31, 2025 24.47 Mn
May 31, 2025 13.52 Mn
May 31, 2025 13.52 Mn
Feb 28, 2025 -119,000.00
Feb 28, 2025 -119,000.00
Nov 30, 2024 -10.73 Mn
Nov 30, 2024 -10.73 Mn
Aug 31, 2024 -49.40 Mn
Aug 31, 2024 -49.40 Mn
May 31, 2024 45.06 Mn
May 31, 2024 45.06 Mn
Feb 29, 2024 28.09 Mn
Feb 29, 2024 28.09 Mn
Nov 30, 2023 81.50 Mn
Nov 30, 2023 81.50 Mn